Guide

Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD)

Prepare for ICH M15 guideline: Learn how to assess model credibility, align terminology, and strengthen…

Certara2026 年 2 月 13 日

On-Demand Webinar

The “Easy Button” for PK/PD TFLs and Reports (TFL Studio & AI PK Reports)

Watch to see how Phoenix TFL Studio and AI PK Reports automate the final stages…

Certara2026 年 2 月 12 日

Blog

Pediatric drug development: From “wild west” to model-informed confidence

Model-informed drug development and precision dosing are transforming pediatric programs, from regulatory planning to Bayesian…

Certara2026 年 2 月 11 日

Live Events

Phoenix Roadshow 2026 – Florence

Certara2026 年 2 月 2 日

Publication

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…

Certara2026 年 2 月 2 日

On-Demand Webinar

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

Discover population PK modeling made faster and easier with Phoenix NLME and Pirana in this…

Certara2026 年 1 月 30 日

On-Demand Webinar

Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)

This on demand session demonstrates how Phoenix WinNonlin® and other tools work together within Phoenix®…

Certara2026 年 1 月 27 日

Conference

Quantitative Systems Pharmacology Conference

Certara2026 年 1 月 26 日

Blog

How model-informed drug development (MIDD) strengthens drug asset valuation and answers the questions investors care about most

Learn how Model-Informed Drug Development strengthens drug asset valuation by reducing uncertainty, predicting clinical performance,…

Certara2026 年 1 月 26 日

Webinar

Milliliters, Milligrams, and Moles: Keeping Up with Units in NCA

Danielle Pillsbury2026 年 1 月 22 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

Modeling and Simulation – PK/PD

Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD)

The “Easy Button” for PK/PD TFLs and Reports (TFL Studio & AI PK Reports)

Pediatric drug development: From “wild west” to model-informed confidence

Phoenix Roadshow 2026 – Florence

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

Modeling Population PK with Power, Speed, and Ease-of-Use (Phoenix® NLME & Pirana®)

Regulatory-Trusted Software for Smarter PK/PD Workflows (Phoenix WinNonlin®)

Quantitative Systems Pharmacology Conference

How model-informed drug development (MIDD) strengthens drug asset valuation and answers the questions investors care about most

Milliliters, Milligrams, and Moles: Keeping Up with Units in NCA

订阅时事通讯

快捷链接

解决方案

联系我们